机构:[1]Institute of Nephrology, and Zhanjiang Key Laboratory of Prevention and Management of Chronic Kidney Disease, Guangdong Medical University, Zhanjiang 524001 Guangdong, China [2]Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Shipping warehouse No. 5, 100700 Beijing, China
Autophagy, the intracellular lysosomal degradation process plays a pivotal role in podocyte homeostasis in diabetic kidney disease (DKD). Lysosomal function, autophagic activity, and their actions were investigated in vitro and in vivo. We found that LC3-II- and p62-positive vacuoles accumulated in podocytes of patients with DKD. Moreover, we found that advanced glycation end products (AGEs) could increase the protein expression of LC3-II and p62 in a dose- and time-dependent manner in cultured podocytes. However, the mRNA expression of LC3B, Beclin-1 or ATG7, as well as the protein level of Beclin-1 or ATG7 did not change significantly in the AGE-treated cells compared with that in control groups, suggesting that AGEs did not induce autophagy. In addition, AGEs led to an increase in the number of autophagosomes but not autolysosomes, accompanied with a failure in lysosomal turnover of LC3-II or p62, indicating that the degradation of autophagic vacuoles was blocked. Furthermore, we observed a dramatic decrease in the enzymatic activities, and the degradation of DQ-ovalbumin was significantly suppressed after podocytes were treated with AGEs. Plasma-irregular lysosomal-associated membrane protein 1 granules accompanied with the diffusion of cathepsin D expression and acridine orange redistribution were observed in AGE-treated podocytes, indicating that the lysosomal membrane permeability was triggered. Interestingly, we also found that AGEs-induced autophagic inhibition and podocyte injury were mimicked by the specific lysosomotropic agent, L-leucyl-L-leucine methyl ester. The exacerbated apoptosis and Rac-1-dependent actin-cytoskeletal disorganization were alleviated by an improvement in the lysosomal-dependent autophagic pathway by resveratrol plus vitamin E treatment in AGE-treated podocytes. However, the rescued effects were reversed by the addition of leupeptin, a lysosomal inhibitor. It suggests that restoring lysosomal function to activate autophagy may contribute to the development of new therapeutic strategies for DKD.
基金:
We thank Dr. Jochen Reiser (Rush University Medical) and Dr. Wei Shi
(Guangdong General Hospital) for kindly providing the mouse podocyte cell
line MPC-5. This study was supported by funds from the National Natural
Science Foundation of China (grant number 81570656).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类|2 区生物
小类|2 区细胞生物学
最新[2025]版:
大类|1 区生物学
小类|2 区细胞生物学
第一作者:
第一作者机构:[1]Institute of Nephrology, and Zhanjiang Key Laboratory of Prevention and Management of Chronic Kidney Disease, Guangdong Medical University, Zhanjiang 524001 Guangdong, China [2]Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Shipping warehouse No. 5, 100700 Beijing, China
通讯作者:
推荐引用方式(GB/T 7714):
Liu Wei Jing,Gan Yu,Huang Wei Fang,et al.Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease.[J].Cell death & disease.2019,10(11):806.doi:10.1038/s41419-019-2002-6.
APA:
Liu Wei Jing,Gan Yu,Huang Wei Fang,Wu Hong-Luan,Zhang Xue-Qin...&Liu Hua-Feng.(2019).Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease..Cell death & disease,10,(11)
MLA:
Liu Wei Jing,et al."Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease.".Cell death & disease 10..11(2019):806